|
1
|
Lysov Z, Dwivedi DJ, Gould TJ and Liaw PC:
Procoagulant effects of lung cancer chemotherapy: Impact on
microparticles and cell-free DNA. Blood Coagul Fibrinolysis.
28:72–82. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sherwood JL, Corcoran C, Brown H, Sharpe
AD, Musilova M and Kohlmann A: Optimised pre-analytical methods
improve KRAS mutation detection in circulating tumour DNA (ctDNA)
from patients with non-small cell lung cancer (NSCLC). PLoS One.
11:e01501972016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Taverna S, Giallombardo M, Gil-Bazo I,
Carreca AP, Castiglia M, Chacártegui J, Araujo A, Alessandro R,
Pauwels P, Peeters M and Rolfo C: Exosomes isolation and
characterization in serum is feasible in non-small cell lung cancer
patients: Critical analysis of evidence and potential role in
clinical practice. Oncotarget. 7:28748–28760. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ferlay J, Steliarova-Foucher E,
Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, Forman D and
Bray F: Cancer incidence and mortality patterns in Europe:
Estimates for 40 countries in 2012. Eur J Cancer. 49:1374–1403.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tian Y, Liu Q, He X, Yuan X, Chen Y, Chu Q
and Wu K: Emerging roles of Nrf2 signal in non-small cell lung
cancer. J Hematol Oncol. 9:142016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yongchun Z, Linwei T, Xicai W, Lianhua Y,
Guangqiang Z, Ming Y, Guanjian L, Yujie L and Yunchao H:
MicroRNA-195 inhibits non-small cell lung cancer cell
proliferation, migration and invasion by targeting MYB. Cancer
Lett. 347:65–74. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Xie Z, Cai L, Li R, Zheng J, Wu H, Yang X,
Li H and Wang Z: Down-regulation of miR-489 contributes into NSCLC
cell invasion through targeting SUZ12. Tumour Biol. 36:6497–6505.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sun L, Chen Y, Su Q, Tang X, Liang Y, Che
G and Luo F: Increased plasma miRNA-30a as a biomarker for
non-small cell lung cancer. Med Sci Monit. 22:647–655. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen QY, Jiao DM, Wu YQ, Chen J, Wang J,
Tang XL, Mou H, Hu HZ, Song J, Yan J and Wu LJ: MiR-206 inhibits
HGF-induced epithelial-mesenchymal transition and angiogenesis in
non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway.
Oncotarget. 7:18247–18261. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ma W, Ma CN, Li XD and Zhang YJ: Examining
the effect of gene reduction in miR-95 and enhanced
radiosensitivity in non-small cell lung cancer. Cancer Gene Ther.
23:66–71. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen X, Chen S, Hang W, Huang H and Ma H:
MiR-95 induces proliferation and chemo- or radioresistance through
directly targeting sorting nexin1 (SNX1) in non-small cell lung
cancer. Biomed Pharmacother. 68:589–595. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li Y, Li Y, Liu J, Fan Y, Li X, Dong M,
Liu H and Chen J: Expression levels of microRNA-145 and
microRNA-10b are associated with metastasis in non-small cell lung
cancer. Cancer Biol Ther. 17:272–279. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xia W, Chen Q, Wang J, Mao Q, Dong G, Shi
R, Zheng Y, Xu L and Jiang F: DNA methylation mediated silencing of
microRNA-145 is a potential prognostic marker in patients with lung
adenocarcinoma. Sci Rep. 5:169012015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang Y and Lin Q: MicroRNA-145 inhibits
migration and invasion by down-regulating FSCN1 in lung cancer. Int
J Clin Exp Med. 8:8794–8802. 2015.PubMed/NCBI
|
|
15
|
Zhang Y, Yang X, Wu H, Zhou W and Liu Z:
MicroRNA-145 inhibits migration and invasion via inhibition of
fascin 1 protein expression in non-small-cell lung cancer cells.
Mol Med Rep. 12:6193–6198. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhao W, Zhao JJ, Zhang L, Xu QF, Zhao YM,
Shi XY and Xu AG: Serum miR-21 level: A potential diagnostic and
prognostic biomarker for non-small cell lung cancer. Int J Clin Exp
Med. 8:14759–14763. 2015.PubMed/NCBI
|
|
17
|
Li X, Zang A, Jia Y, Zhang J, Fan W, Feng
J, Duan M, Zhang L, Huo R, Jiao J and Zhu X: Triptolide reduces
proliferation and enhances apoptosis of human non-small cell lung
cancer cells through PTEN by targeting miR-21. Mol Med Rep.
13:2763–2768. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tian L, Shan W, Zhang Y, Lv X, Li X and
Wei C: Erratum to: Up-Regulation of miR-21 expression predicate
advanced clinicopathological features and poor prognosis in
patients with non-small cell lung cancer. Pathol Oncol Res.
22:4392016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li Z, Li N, Wu M, Li X, Luo Z and Wang X:
Expression of miR-126 suppresses migration and invasion of colon
cancer cells by targeting CXCR4. Mol Cell Biochem. 381:233–242.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang N, Su Y and Xu L: Targeting PKCε by
miR-143 regulates cell apoptosis in lung cancer. FEBS Lett.
587:3661–3667. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nam K, Oh S, Lee KM, Yoo SA and Shin I:
CD44 regulates cell proliferation, migration, and invasion via
modulation of c-Src transcription in human breast cancer cells.
Cell Signal. 27:1882–1894. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang Y, Zhao J, Qiu L, Zhang P, Li J,
Yang D, Wei X, Han Y, Nie S and Sun Y: Co-expression of ILT4/HLA-G
in human non-small cell lung cancer correlates with poor prognosis
and ILT4-HLA-G interaction activates ERK signaling. Tumour Biol.
37:11187–11198. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li Q, Yang Z, Chen M and Liu Y:
Downregulation of microRNA-196a enhances the sensitivity of
non-small cell lung cancer cells to cisplatin treatment. Int J Mol
Med. 37:1067–1074. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jiao A, Sui M, Zhang L, Sun P, Geng D,
Zhang W, Wang X and Li J: MicroRNA-200c inhibits the metastasis of
non-small cell lung cancer cells by targeting ZEB2, an
epithelial-mesenchymal transition regulator. Mol Med Rep.
13:3349–3355. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang S, Gao L, Thakur A, Shi P, Liu F,
Feng J, Wang T, Liang Y, Liu JJ, Chen M and Ren H: miRNA-204
suppresses human non-small cell lung cancer by targeting ATF2.
Tumour Biol. 37:11177–11186. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lindsten T, Ross AJ, King A, Zong WX,
Rathmell JC, Shiels HA, Ulrich E, Waymire KG, Mahar P and Frauwirth
K: The combined functions of proapoptotic Bcl-2 family members bak
and bax are essential for normal development of multiple tissues.
Mol Cell. 6:1389–1399. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Frixa T, Donzelli S and Blandino G:
Oncogenic microRNAs: Key players in malignant transformation.
Cancers (Basel). 7:2466–2485. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Floyd DH, Zhang Y, Dey BK, Kefas B, Breit
H, Marks K, Dutta A, Herold-Mende C, Synowitz M and Glass R: Novel
anti-apoptotic microRNAs 582-5p and 363 promote human glioblastoma
stem cell survival via direct inhibition of caspase 3, caspase 9
and Bim. PLoS One. 9:e962392014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li JH, Xiao X, Zhang YN, Wang YM, Feng LM,
Wu YM and Zhang YX: MicroRNA miR-886-5p inhibits apoptosis by
down-regulating Bax expression in human cervical carcinoma cells.
Gynecol Oncol. 120:145–151. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ye Y, Tang X, Sun Z and Chen S:
Upregulated WDR26 serves as a scaffold to coordinate PI3K/AKT
pathway-driven breast cancer cell growth, migration, and invasion.
Oncotarget. 7:17854–17869. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Safdari Y, Khalili M, Ebrahimzadeh MA,
Yazdani Y and Farajnia S: Natural inhibitors of PI3K/AKT signaling
in breast cancer: Emphasis on newly-discovered molecular mechanisms
of action. Pharmacol Res. 93:1–10. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yakisich JS, Azad N, Venkatadri R,
Kulkarni Y, Wright C, Kaushik V and Iyer AK: Formation of
tumorspheres with increased stemness without external mitogens in a
lung cancer model. Stem Cells Int. 2016:56031352016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sun Y, Tu Y, He LI, Ji C and Cheng BO:
High mobility group box 1 regulates tumor metastasis in cutaneous
squamous cell carcinoma via the PI3K/AKT and MAPK signaling
pathways. Oncol Lett. 11:59–62. 2016.PubMed/NCBI
|
